AAAAI Annual Meeting 2020


Due to the COVID-19 pandemic, The Annual Meeting of the American Academy of Allergy Asthma & Immunology was cancelled for 2020. The theme of this year's meeting was "New Paradigms in the Management of Allergic Disease -- Focus on Biologics."
This resource center will update you on all of the key abstracts from AAAAI 2020 to ensure that you do not miss any of the crucial, practice-changing research that was conducted for presentation at the 2020 Annual Meeting.
Top 5 Abstracts from AAAAI 2020

Top 5 Abstracts from AAAAI 2020

Due to COVID-19, the AAAAI Annual Meeting was canceled and the research released to the public. Research highlights included long-term studies from new biologics and important advances in asthma, atopic dermatitis, and immunology care...
Dupilumab Quickly Improves Itching Symptoms in Atopic Dermatitis

Dupilumab Quickly Improves Itching Symptoms in Atopic Dermatitis

Adolescents and adults with atopic dermatitis (AD) saw improvement in itching symptoms as early as two days after starting on dupilumab...
Mepolizumab Reduces Exacerbations in Patients with Asthma, Comorbid Conditions

Mepolizumab Reduces Exacerbations in Patients with Asthma, Comorbid Conditions

Asthma patients with comorbid conditions such as nasal polyps, sinusitis, or allergic rhinitis had a reduced number of exacerbations and better health-related quality of life after receiving mepolizumab...
FeNO Predicts Exacerbations in Patients with Moderate-to-Severe Asthma

FeNO Predicts Exacerbations in Patients with Moderate-to-Severe Asthma

Fractional exhaled nitric oxide (FeNO) may be a reliable biomarker for predicting exacerbations in patients with moderate-to-severe asthma...
Benralizumab Demonstrates Safety, Efficacy at 3 Years for Moderate-to-Severe Asthma

Benralizumab Demonstrates Safety, Efficacy at 3 Years for Moderate-to-Severe Asthma

At 3 years, benralizumab (Fasenra; AstraZeneca) continues to lower exacerbation rates and improve lung function in adults and adolescents with severe, uncontrolled asthma...

Loading...

© 2024 /alert® unless otherwise noted. All rights reserved.
Reproduction in whole or in part without permission is prohibited.
Privacy Policy | Terms of Use | Editorial Policy | Advertising Policy